(R)-2-Flurbiprofen(CAS: 51543-40-9)

The (R)-2-Flurbiprofen (CAS: 51543-40-9) is subject to various regulatory guidelines including GHS classification, REACH regulations, and FDA/EPA requirements. It is classified as a non-steroidal anti-inflammatory drug (NSAID) and must comply with safety and labeling standards for pharmaceuticals. Companies must ensure compliance with these guidelines during manufacturing, storage, and distribution to meet international safety and regulatory requirements.

Yes, there are alternatives to (R)-2-Flurbiprofen (CAS: 51543-40-9) in synthesis, such as other NSAIDs like ibuprofen or naproxen. Isomers and analogs, such as (S)-2-flurbiprofen, can also be used. Common alternative reagents include different chiral auxiliaries or asymmetric synthesis methods to produce enantiopure compounds. These alternatives can provide similar or improved pharmacological properties depending on the specific application.

The market for (R)-2-Flurbiprofen (CAS: 51543-40-9) is stable due to its established therapeutic use as a non-steroidal anti-inflammatory drug. Research trends focus on understanding its mechanism of action, potential for treating inflammatory conditions, and minimizing side effects. Recent studies also explore the potential of (R)-2-Flurbiprofen in combination therapies and its role in chronic pain management. The trend shows increasing demand for effective and safe NSAIDs in the pharmaceutical industry.

Waste containing (R)-2-Flurbiprofen (CAS: 51543-40-9) should be handled according to appropriate disposal regulations. Waste liquid should be collected in suitable containers and neutralized to a pH of 7-8 before disposal. Incineration or professional waste disposal services are recommended to ensure complete destruction of the compound. Environmental protection precautions include proper containment to prevent contamination and adherence to local and international waste disposal guidelines to ensure safe and sustainable management of waste.